Scientific Industries’ revenue fell 3.5% year over year, primarily due to reduced Bioprocessing Systems sales. Earnings declined as the prior-year period included a larger gain from the Genie product line disposition; the current quarter also recorded a $1.7M gain. Gross margin improved to 54.8% from 45.5%.
Financial Highlights
| Metric | Current quarter | Prior year quarter | YoY change |
| Revenue¹ | $1.35M | $1.4M | (3.5%) |
| Net income² | $470K | $3.99M | (88.2%) |
| Diluted EPS³ | $0.04 | $0.34 | (88.2%) |
¹ Reported as “Revenues”. ² Reported as “Net income (loss)”. ³ Reported as “Consolidated operations”.
Business Highlights
- Bioprocessing Systems: Revenue was $295,900, down from $335,700, primarily driving the quarterly revenue decline.
- Benchtop Laboratory Equipment: Revenue was $1.1M, compared with $1.1M a year earlier.
- Gross margin: Increased to 54.8% from 45.5%, primarily on higher-margin DOTS product sales in Bioprocessing Systems.
- Cost reductions: General and administrative expenses fell 15.7% and selling expenses declined 16.4% year over year.
Original SEC Filing: SCIENTIFIC INDUSTRIES INC [ SCND ] – 10-Q – Nov. 13, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.